News & events.

Our news.

Filter by Category
Filter by Year
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News
May 11, 2021
2021

AbCellera to Present Virtually at Berenberg Conference on May 18, 2021

Read article
News
May 6, 2021
2021

AbCellera Partners with Angios to Develop Therapeutics to Combat Blindness Caused by Diabetic Retinopathy

Read article
News
May 4, 2021
2021

New AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404, Enters Clinical Trials

Read article
News
April 29, 2021
2021

AbCellera Breaks Ground on Global Headquarters in Vancouver and Expects to Hire Hundreds of Scientific and Tech Professionals

Read article
News
April 21, 2021
2021

AbCellera to Report First Quarter 2021 Financial Results on May 13, 2021

Read article
News
April 14, 2021
2021

AbCellera and Empirico Announce Strategic Multi-Target Antibody Discovery Collaboration

Read article
News
April 12, 2021
2021

AbCellera to Present Virtually at Upcoming Investor Conferences

Read article
Event
April 7, 2021
2021

SynBioBeta Biopharma Day 2021

Read article
News
April 5, 2021
2021

Published Peer-Reviewed Data Demonstrate Bamlanivimab’s High Potency Against SARS-CoV-2 and Support its Use as a Foundational Antibody Therapy to Treat and Prevent COVID-19

Read article
News
April 1, 2021
2021

AbCellera and Gilead Sciences Announce New Multi-Year, Multi-Target Antibody Discovery Collaboration

Read article